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Current Exercise Behaviors of Breast Cancer Patients Diagnosed with
Chemotherapy-Induced Peripheral Neuropathy
Abstract

Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of
cancer therapy. The neuropathic pain associated with CIPN often has negative implications on an individual’s
quality of life (QOL) and has long been recognized as one of the more difficult types of pain to treat.
Treatment of neuropathic pain due to CIPN often requires a multidisciplinary approach, with much attention
focused on the use of pharmacological therapies. However, in most instances, these agents have been shown to
have additional negative side effects for cancer patients. Thus, other interventions that address the symptoms
of CIPN should be considered. One such possible intervention is exercise rehabilitation, which has previously
been reported effective in attenuating numerous cancer treatment-related toxicities and enhancing the QOL
of patients. However, to our knowledge, there have been no published clinical trials examining the role of
exercise in preserving neurological function following chemotherapy. As such, the purpose of this
investigation was to examine the current exercise habits of breast cancer patients who are diagnosed with
CIPN and the impact on pain and QOL.
Methods: 300 women listed in the Breast Cancer Registry of Greater Cincinnati database were recruited by
mail and asked to complete three questionnaires (McGill QOL, Leeds Assessment of Neuropathic Symptoms
and Signs, and Current Exercise Behaviors). Data was analyzed at the 0.05 level of significance using a
student’s t-test and a Pearson’s product moment correlation.
Results: 134 completed surveys were returned and analyzed (44.6% response rate). Overall, QOL and
exercise behaviors were moderately correlated (r = 0.56). Patients reported exercising an average of 2.3 d/wk
and an overall QOL of 4.7. Of the patients completing the recommended amount of physical activity (EX, n =
21), QOL was 6.3, which was significantly higher than patients who did not meet these recommendations
(SED, n = 113, p<0.001). Likewise, only 15% of EX patients reported experiencing pain compared to 72% of
SED patients (p<0.001). Conclusions: Based on these data, it seems likely that an exercise intervention would
be successful in attenuating symptoms of CIPN and improving the overall QOL of breast cancer patients.
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Abstract
Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of cancer
therapy. The neuropathic pain associated with CIPN often has negative implications on an individual’s quality of life
(QOL) and has long been recognized as one of the more difficult types of pain to treat. Treatment of neuropathic pain
due to CIPN often requires a multidisciplinary approach, with much attention focused on the use of pharmacological
therapies. However, in most instances, these agents have been shown to have additional negative side effects for
cancer patients. Thus, other interventions that address the symptoms of CIPN should be considered. One such
possible intervention is exercise rehabilitation, which has previously been reported effective in attenuating numerous
cancer treatment-related toxicities and enhancing the QOL of patients. However, to our knowledge, there have been
no published clinical trials examining the role of exercise in preserving neurological function following chemotherapy.
As such, the purpose of this investigation was to examine the current exercise habits of breast cancer patients who
are diagnosed with CIPN and the impact on pain and QOL.
Methods: 300 women listed in the Breast Cancer Registry of Greater Cincinnati database were recruited by mail
and asked to complete three questionnaires (McGill QOL, Leeds Assessment of Neuropathic Symptoms and Signs,
and Current Exercise Behaviors). Data was analyzed at the 0.05 level of significance using a student’s t-test and a
Pearson’s product moment correlation.
Results: 134 completed surveys were returned and analyzed (44.6% response rate). Overall, QOL and exercise
behaviors were moderately correlated (r = 0.56). Patients reported exercising an average of 2.3 d/wk and an overall
QOL of 4.7. Of the patients completing the recommended amount of physical activity (EX, n = 21), QOL was 6.3, which
was significantly higher than patients who did not meet these recommendations (SED, n = 113, p<0.001). Likewise,
only 15% of EX patients reported experiencing pain compared to 72% of SED patients (p<0.001). Conclusions:
Based on these data, it seems likely that an exercise intervention would be successful in attenuating symptoms of
CIPN and improving the overall QOL of breast cancer patients.

Keywords: Chemotherapy-induced peripheral neuropathy; Exercise
behaviors; Quality of life; Pain

Introduction
Chemotherapy- induced peripheral neuropathy (CIPN) is a common ailment among those taking chemotherapeutic drugs. This condition is characterized by damage to the nervous system that is a direct
result of the medications associated with chemotherapy. Little is known
about the mechanisms responsible for the development of CIPN [1].
The peripheral toxicity involved with CIPN is specific to each chemotherapy drug class, and in most cases, appears to be dose and duration
dependent, however it can evolve even after a single drug application
[2]. The chemotherapy agents Docetaxel, Paclitaxel, or Vinorelbine are
used to treat breast cancer, and often result in damage to central nervous system pain pathways, resulting in neuropathic pain [3-6]. The
presence and severity of neuropathic pain is often shown to be associated with impairments in walking, general activities, sleep, work, mood,
enjoyment of life, and relationships with others [7,8].
Much effort has been made to explore pharmacological therapies to
reduce CIPN. Some of these therapies provide modest improvements
in neurological function. However, in most instances, these agents have
been shown to have additional negative side effects for cancer patients,
such as cardiac conduction defects, abnormalities in antidiuretic hormone secretion, loss of balance, swelling in extremities, tremor, and increased chemotherapy resistance [9-11]. Thus, other interventions that
address the symptoms of CIPN should be considered. One intervention
that has the potential of preventing or alleviating CIPN is exercise rehaJ Integr Oncol
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bilitation. Exercise has been shown to have a local effect on peripheral
nerves, inducing changes in both the vasculature and metabolic systems [12]. Short-term exercise stimulates endothelium-dependent vasodilatation and endoneurial blood flow [13]. Long-term exercise has
a positive effect on oxygen delivery, as increased blood flow exposes
blood vessels to shear stress, which augments vasodilation [13]. Several
studies have illustrated the beneficial effects of exercise in attenuating
numerous cancer treatment-related toxicities and enhancing the quality of the lives of patients [14-21]. In addition, numerous studies on the
effect of exercise in populations with diabetic peripheral neuropathy
have produced promising results [22-24]. However, published clinical
trials examining the role of exercise in preserving neurological function
following chemotherapy are limited. Since breast cancer survivors represent the largest population of cancer survivors in the United States,
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the purpose of this investigation was to examine the current exercise
behaviors of breast cancer patients who were diagnosed with CIPN and
to determine the resulting impact on their pain and quality of life.

Methods

Age at time of Age at time of Education Level Race
survey (yrs)
diagnosis (yrs)
54.9 ± 2.4

50.4 ± 5.7

Subjects

Data collection
The 300 women who met the eligibility criteria and agreed to be
contacted received a packet that included a cover letter, the McGill
Quality of Life questionnaire [25], the Leeds Assessment of Neuropathic Symptoms and Signs questionnaire (LANSS) [26], a questionnaire
to measure current exercise behaviors (Reigle), and a self-addressed,
stamped envelope. Women were asked to return the completed questionnaires within two weeks of receiving the packet. Women who did
not respond within two weeks were sent a reminder postcard.

Data analysis
Descriptive statistics have been computed as means and standard
deviations. A Pearson’s product moment correlation was used to determine the relationship between QOL and current exercise behaviors
for the group as a whole. A student’s T-test was used to compare the
overall QOL ratings, as well as the prevalence of pain ratings, among
patients who received the recommended amount of exercise compared
to those who did not. All data was analyzed at the 0.05 level of significance.

Results
Of the 300 surveys sent out, 134 completed surveys were returned
and analyzed, giving a 44.6% response rate. The characteristics of the
patients are summarized in Table 1. The distribution of QOL was normal. On average, patients reported exercising 2.3 d/wk (approximately
69 min/wk) and rated their overall quality of life (QOL) as 4.7 on a
10-point scale. CIPN impacted routine activities, functions, and behaviors in the areas of domestic, work, and social/leisure life. A moderate
correlation was measured between QOL and current exercise behaviors
for the group as a whole (r = 0.56). Table 2 summarizes the results of
the Exercise Behaviors Survey for all respondents. Table 3 presents the
results of the LANSS survey for all respondents.
Responses were analyzed to determine the percentage of patients
completing the recommended amount of physical activity (at least 150
min moderate-intense ex/wk and muscle strengthening activity 2 d/wk
J Integr Oncol
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36 = high school White = 105 4.5 ± 6.4 mo’s
68 = college
Black = 21
30 = postgrad
Hispanic = 6
Other = 2

Table 1: Subject Characteristics. Values are means ± SE.
Type of Exercise

Frequency/wk

Increase flexibility of arms and shoulders

2.39 ± 0.10

Increase strength of arms and shoulders

2.16 + 0.10

Increase flexibility of legs

2.48 + 0.11

Increase strength of legs

2.45 + 0.10

Increase strength and flexibility of upper body

2.16 + 0.10

Increase strength and flexibility of lower body

2.35 + 0.10

Balance exercises

2.03 + 0.11

Resistance training

1.97 + 0.09

Table 2: Results from Exercise Behaviors Survey. Values are means ± SE.
Questions

% of respondents
answering Yes

Would you describe your pain as pricking, tingling, pins and 51 ± 1.2%
needles?
Does the skin in the painful areas look different than normal? 17.9 ± 0.5%
Is the skin sensitive to touch?

33.3 ± 1.7%

Does your pain come on suddenly in bursts when you are
still?

42.3 ± 1.1%

Do you feel that skin temperature in the painful area has
changed?

20.5 ± 2.1%

Does stroking the affected area with cotton wool produce
pain?

9.2 ± 0.3%

Table 3: Results from LANSS Survey. Values are means ± SE.
8
7

Overall quality of life ratings

This investigation used a non-probability sample of convenience.
Women who met the eligibility criteria and were listed in the Breast
Cancer Registry of Greater Cincinnati (BCRGC) database were recruited by mail in the fall of 2010. The eligibility criteria included women
who (a) have recently received a clinical diagnosis of CIPN, and (b)
were currently taking the chemotherapy agents Docetaxel, Paclitaxel, or Vinorelbine, and (c) were able to read and write English. The
BCRGC is a database established by the University of Cincinnati, Department of Environmental Health for the purpose of supporting studies that focus on breast cancer issues. Women who were breast cancer
survivors and were located in the Greater Cincinnati area may become
members by signing a consent form and completing a registration form
that includes questions specific to the detection, diagnosis, and treatment of their disease. A total of 300 women listed in the BCRGC met
the eligibility criteria of the study. All procedures were approved by
the Wright State University Institutional Review Board prior to data
collection.

Length of
Cancer
Treatment

*

6
5
4
3
2
1
0

EX

SED

Figure 1: Overall Quality of Life Ratings. Values are means ± SE. *p<0.001
vs. SED.

[27]. Approximately 15.6% of the patients surveyed reported meeting
these recommended levels of physical activity (EX, n = 21). This group
of patients reported an overall QOL of 6.3. As demonstrated in (Figure
1), this was significantly higher than those patients who did not meet
these recommendations (SED, n = 113), who reported an average overall QOL of 3.4 (p<0.001). Similarly, only 15% of EX patients reported
experiencing pain compared to 72% of SED patients (p<0.001) (Figure
2). The pain was frequently described as “tingling” and “numbness”
and localized to “hands and feet”. Several respondents (n = 46) indicated that this pain was “better when I exercise”.
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Prevalence of Pain
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Figure 2: Prevalence of Pain Ratings. Values are means ± SE. *p<0.001
vs. EX.

Discussion
The major finding in this investigation was that breast cancer patients with CIPN who received the recommended levels of physical
activity reported a significantly higher overall QOL and experienced
significantly less pain than their sedentary counterparts. CIPN affected breast cancer patients’ routine activities, functions, and behaviors. While it is unknown if the sedentary individuals abstained from
exercise because of their pain, the respondents who stated that their
pain was “better when I exercise” indicates that it seems likely that an
exercise intervention would be successful in attenuating symptoms of
CIPN and improving the overall QOL of breast cancer patients.
With neuropathy, muscle mass atrophies and leads to significant
decreases in muscular strength [28]. This decline in strength appears to
be slow and progressive. It also appears to affect distal muscle groups
more so than proximal muscles. Researchers have indicated that this
muscle weakness translates into impaired motor performance skills
and a reduced exercise capacity [29]. However, several studies have reported improvements in muscular strength following moderate resistance exercise programs in patients with hereditary motor and sensory
neuropathies [30,31], as well as diabetic neuropathies, and those associated with fibromyalgia and chronic fatigue [32-37]. In light of these
findings, many researchers recommend that exercise training serve
as an important component in the comprehensive treatment plan for
patients with peripheral neuropathy [33,34,38]. Moderate-to-intense
strength training and aerobic exercise appears to be well tolerated by
these patients [38], and is associated with improvements in motor
function and nerve conduction velocity [32,35], as well as improved
muscle reinnervation and increased axon regeneration [39]. In addition, one investigation reported that low intensity treadmill exercise
promoted Schwann cell proliferation in the injured peripheral nerve
[40]. In light of these findings, it is feasible to assume that an individual
who has experienced a reduction in muscular strength and functional
ability due to CIPN may experience similar improvements following
an exercise program.
It is not uncommon for individuals with cancer to experience pain.
This pain may be triggered by the disease itself, or by its associated
treatments. The direct effect of the tumor accounts for about 70% of
the pain related to cancer, while approximately 15% of cancer pain is
related to its treatments [41]. The pain associated with CIPN has long
been recognized as one of the more difficult types of pain to treat.
However, as explained earlier, it is possible that exercise may have a
beneficial effect on pain. As illustrated by the respondents in the curJ Integr Oncol
ISSN: JIO an open access journal

rent study, those individuals who exercised experienced significantly
less pain than their sedentary counterparts. Likewise, it was noted that
pain became “better” upon exercise. This finding is supported by several studies conducted on healthy populations, whereby pain thresholds and tolerance levels have been reported to increase both during
and following exercise. In addition, intensity ratings of pain appear to
decrease following exercise [42,43].
While literature examining the role of exercise on symptoms of
pain related to CIPN is lacking, we believe that the existing tangential
research supports the use of exercise as a means to attenuate general
cancer related pain. Exercise during cancer treatment has been shown
to have a beneficial effect on pain for breast cancer patients [44-47]. In a
similar study to ours, Liou et al. [45] surveyed the daily physical activity
levels of individuals who were undergoing chemotherapy, but were not
diagnosed with CIPN. These authors reported that those patients who
received the recommended 150 min/wk of moderate activity reported
significantly less symptoms of pain than their sedentary counterparts.
In light of the findings and the literature surrounding this topic,
it seems feasible to assume that a supervised exercise program would
provide a beneficial effect on quality of life and pain associated with
CIPN in breast cancer patients. More follow up investigations are warranted.

Limitations
The most apparent limitation in the present study is the low response rate from the breast cancer patients (44.6%). However, in survey research, no single response rate is considered a standard [48]. Mail
surveys typically have lower response rates than other types of surveys
[49]. In the present study, non respondents were sent a reminder postcard in an attempt to increase the response rate; however, additional
measures could have also been employed, such as personal contact. In
addition, due to the lack of existing literature examining the effects of
exercise on symptoms of CIPN, the authors had to look to the effects of
exercise on symptoms of peripheral neuropathy in other chronic diseases (i.e., diabetes) to make its generalizations. Thus, it is possible that
an exercise program may not produce similar results in a breast cancer
patient. Likewise, since the location of cancer will vary the symptoms
related to CIPN, it is possible that the exercise response would produce
a different outcome in another form of cancer.
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